The United States Patent and Trademark Office (USPTO) has granted patent US12582621B2 for novel compositions and methods related to the delivery of pharmaceutical agents. The patent specifically covers hydrogel formulations of suramin, intended for applications in wound healing and prevention. The assignee is the Arizona Board of Regents on behalf of the University of Arizona, with Heidi M. Mansour, Rick G. Schnellmann, and David Encinas listed as inventors.

This patent grant is primarily an intellectual property event. While it signifies innovation in pharmaceutical delivery systems, it does not impose new regulatory obligations or compliance requirements on drug manufacturers or other entities. Companies operating in the pharmaceutical and medical device sectors should be aware of this patent as it may affect their freedom to operate or potential licensing opportunities related to suramin-based hydrogel formulations for wound care.